Queensland Life Sciences Industry Report 2012 (PDF, 3.5MB)

More documents

Recommendations

Info

Queensland Life Sciences Industry Report 2012 82 14.APPENDICES 14.1 Methodology The following section defines the data sources used in the study; limitations of the data collected; and data that was unavailable. 14.1.1 Primary Data All primary data included in this report was collected from QLS companies and research organisations through an industry survey conducted in March and April 2012. The methodology employed to conduct the survey is described below. 14.1.2 Defining the Queensland Life Sciences Industry For the purpose of the QLS Survey 2011, the QLS Industry was defined as any company, university institute, faculty, school or centre or research institution that is undertaking Life Sciences related activities in one or more of the industry sub-sectors described below. These sub-sectors were adapted from the AusBiotech definition of Biotechnology in combination with Pharmaceutical industry definitions.
Industry Sector Examples Human health: Pharmaceuticals, vaccines or drug discovery Human health: Complementary medicines, nutraceuticals Human health: Functional foods Human health: Diagnostics Human health: Medical devices and equipment (e.g. vaccines, immune stimulants, biopharmaceuticals, rational drug design or combinatorial chemistry) (e.g. gene identification, gene constructs, gene delivery or xenotransplants) (e.g.DNA/RNA/protein sequencing and databases for humans, plants, animals and microorganisms or structure function studies) (e.g. probiotics, unsaturated fatty acids) (e.g. immunodiagnostics, gene probes or biosensors) (e.g. MRI) Animal health genetic engineering, animal breeding or anti-microbials) Agricultural biotechnology (e.g. tissue culture, embryogenesis, genetic markers, genetic engineering, plant breeding, floriculture, forestry) (e.g. biofertilisers, biopesticide, bioherbicides, biological additives, microbial pest control, hormones, pheromones, and other agrichemicals) Food biotechnology (e.g. Food products, food components, enzymes, yeasts, bacteria culture) Environmental (e.g. treatment of organic emissions to air/water) (land, air, water) or toxic waste sites (e.g. detection of toxic substances using bioindicators, biosensors or immunodiagnostics) bioprocessing (e.g. biopulping, biobleaching) Marine Industrial (white biotechnology) (e.g. peptides, proteins, nucleotides, hormones, growth factors) (e.g. monomers, fuels, lubricants, fine chemical feed stocks, cosmetics) alternative energy; development of novel biomaterials; use of plants and enzymes to generate industrial products as pollution and waste generation, for the same level of industrial production Bioinformatics management, mining and use of life-science information Industry service provider regulatory consultants, business consultants and other industry service providers 83
Page 1 and 2:
Queensland Life Sciences Industry R
Page 3 and 4:
Since VenturePro was established in
Page 5 and 6:
Strata were defined by industry (TM
Page 7 and 8:
TABLE OF CONTENTS IMPORTANT NOTICE
Page 9 and 10:
Queensland’s listed Life Sciences
Page 12 and 13:
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30:
Page 33 and 34: 5.2 Total Estimated Life Sciences I
Page 35 and 36: TABLE 22: IBISWorld industry statis
Page 37 and 38: TABLE 28: Wage and Salary Expenditu
Page 39 and 40: Research organisations reported tha
Page 42 and 43: Queensland Life Sciences Industry R
Page 62: Queensland Life Sciences Industry R
Page 65 and 66: 10.2 Finance 10.2.1 Debt and Equity
Page 67 and 68: Figure 33: Number of patent applica
Page 69 and 70: By Anne-Marie Birkill, Partner at O
Page 71 and 72: 11.1.2 Contract Manufacturing Half
Page 73 and 74: Figure 43: Importance of Queensland
Page 90: Queensland Life Sciences Industry R
show all

Queensland Life Sciences Industry Report 2012 (PDF, 3.5MB)

Create successful ePaper yourself

Delete template?

Save as template?